Awards & Achievements:-

• Selected for International travel grant awardee (1000USD and waived off Regd. fees) to attain International Congress of Parkinson’s Disease and Movement Disorder, organized by the Movement Disorder Society which held on August 27-31, 2023 in Copenhagen.
• Awarded 2^nd prize for oral presentation at 5^th International FDP on Emerging trends in Neurodegerative disorder: Diagnostic and therapeutic, held on 5-9 May 2025, organized by the DYP DPU School of Pharmacy and Research, Pune
• I have selected for Project Management Unit for PRIP scheme on contract basis as a Young Professional (Tech.) in the department of Pharmaceuticals, Ministry of Chemicals and Fertilizer, Govt. of India.
• Awarded 1st Place for poster presentation in NIPER student research symposium 2023, Celebrating Silver Jubilee of NIPER Act, held at NIPER-Mohali, Punjab in August 2023.
• Selected as Distinguished Speaker for the prestigious event on 2nd Global Summit on Earth Science and Climate Change (Adv. ESCC 2023), which will be held on September 2023, London, United Kingdom. (Selected for Oral presentation (Virtual) which entitled “Chlorogenic Acid: A Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion”).
• Awarded 1st place for oral presentation entitled in the scientific session in PharmaQuora 2018, held at Manipal College of Pharmaceutical Sciences, MAHE, Manipal in March 2018.

Total Conference Attended National & International:- 

• Selected as an International delegate to present a Doctoral thesis in International Congress of Parkinson’s Disease and Movement Disorder, organized by the Movement Disorder Society which held on August 27-31, 2023 in Copenhagen, Denmark. Specially, selected for International travel grant awardee (1000USD and waived off Regd. fees) to attain the congress.
• Participated in NIPER student research symposium 2023, Celebrating Silver Jubilee of NIPER Act, held at NIPER-Mohali, Punjab in August 2023.
• Participated as Delegate in the International Conference on Neurological Disorders and Therapeutics (ICNDT) organized by NIPER-Ahmedabad (An institute of National Importance, Department of Pharmaceuticals, Ministry of Chemical and Fertilizer, Govt. of India), Gandhinagar, India in October 2019.
• Participated as Delegate in the 6th International Congress of Society for Ethnopharmacology (SFEC), India association with Manipal College of Pharmaceutical Sciences and Centre for Integrative Medicine and Research, Manipal Academy of Higher Education, held at Manipal, India in February 2019.
• Participated and presented a poster in the 4th International Conference on Translational Research: Recent development and Innovation in Human Health and Agriculture Research, held at Goa, India in October 2018.
• Participated in the Drug Discovery & Development Concept, Clinic & Commercialisation workshop held at the National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad in March 2018.

Total Publications:- 

• Chatterjee, S.; Verma, A.; Thakkar, H.; Shah, R. P.; Khairnar, A. Glycated -alpha-synuclein Renders Glial cell Activation and induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson’s Disease. ACS Chemical Biology 2025 Mar 21;20(3):632-645. doi: 10.1021/acschembio.4c00777 [IF: 3.5].
• Thakkar, H.; Chatterjee, S.; Verma, A.; Chandrasekar N.; Khairnar A.; Shah R. P. Malondialdehyde-Mediated Alpha-Synuclein Aggregation: A Plausible Etiology of Parkinson’s Disease in Oxidative Stress. Chemical Research in Toxicology 2025 Apr 21;38(4):573-582. doi: 10.1021/acs.chemrestox.4c00348 [I.F: 3.7].
• Thakkar, H.*; Chatterjee, S.*; Saxena, P.; Eerla, R.; Wagh, S.; Khairnar, A.; Shah, R. P. Cell-Engineered Recombinant -α Synuclein: A Gage R&R Validated Protocol. Journal of Proteome Research 2024 Jan 5;23(1):16-24. doi: 10.1021/acs.jproteome.3c00190. (*Joint First author) [I.F: 3.8].
• Chatterjee, S.; Nalla, L. V.; Sharma, M.; Sharma, N.; Singh, A. A.; Malim, F. M.; Ghatage, M.; Mukarram, M.; Parekh, A.; Parihar, N.; Arya, N.; Khairnar, A. Association of COVID-19 with Comorbidities: An Update. ACS Pharmacology & Translational Science 2023 Feb 27;6(3):334-354. doi: 10.1021/acsptsci.2c00181. [I.F: 5.1].
• Sharma, N.; Soni, R.; Sharma, M.; Chatterjee, S.; Parihar, N.; Mukarram, M.; Sayyed, A. A.; Behera, S. K.; Khairnar, A. Chlorogenic Acid: A Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion. Mol- ecular Neurobiology 2022 Nov;59(11):6834-6856. doi: 10.1007/s12035-022-03005-z [I.F: 4.6].
• Sharma, M.; Malim, F. M.; Goswami, A.; Sharma, N.; Juvalapalli, S. S.; Chatterjee, S.; Kate, A. S.; Khairnar, A. J. R. P., Science, T- Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson’s Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation. ACS Pharmacology & Translational Science 2022 Dec 14;6(1):40-51. doi: 10.1021/acsptsci.2c00120 [I.F: 5.1].
• Parekh, P.; Sharma, N.; Sharma, M.; Gadepalli, A.; Sayyed, A. A.; Chatterjee, S.; Kate, A.; Khairnar, A. AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin’s neuroprotection in a rotenone-induced mouse model of Parkinson’s disease. Metabolic Brain Disease 2022 Dec;37(8):2853-2870. doi: 10.1007/s11011-022-01087-1 [I.F: 3.2].
• Bhardwaj, J. S.; Manandhar, S.; Chatterjee, S.; Hari, G.; Priya, K.; Raviteja, S.; Pai, K. S. R. J. R. o. p.; technology. Protective effects of gossypin in colchicine-induced cognitive dysfunction and oxidative damage in rats. 2020, 13(11), 5189 5196. https://doi.org/10.5958/0974-360X.2020.00907.5.

Total Research :-

• To Explore the role of Advanced Glycation End products on Receptor for Advanced Glycation Endproducts (RAGE) signaling pathway in development of Parkinson’s disease’ Under the guidance of Dr. Ravi P Shah and Dr. Amit Khairnar and in this study, we have shown how correlate the missing pieces on glycated α-Syn (which could be generated in diabetes) induced dopaminergic neurodegeneration acting through AGE/RAGE signaling cascade.
• Is Intestinal Inflammation leads to the progression of Parkinson’s disease? Under the guidance of Dr. Amit Khairnar and we have shown how low dose of intragastric rotenone induced the accumulation of alpha-synuclein in intestine and check the transfer of alpha synuclein from gut to brain (Gut-brain axis). Based on this proposal we received the Ramalingaswami Reentry (Fellowship D.O. No. BT/HRD/35/02/2006) from Department of biotechnology (DBT), Ministry of Science and Technology, Govt. of India (Grant amount: Approx 1.60 Cr).
• Chlorogenic acid mediated GLP-1 rlease rendered neuroprotection against rotenone induced Parkinsonian mouse model disease via modulating PI3k/Akt/GSK3β signaling’ Under the guidance of Dr. Amit Khairnar. Animals handing, dosing, performed various animals’ behavioral studies, after completion of study sacrifice and transcardially perfused the animals with 4%PFA and saline, isolation of different parts of brains, like striatum, cortex and whole brain. Performed western blotting of different protein according to our cell signaling cascade. I have done the biochemical estimation (Antioxidant) of animal tissue, like GSH and MDA. In vitro and in-silico docking study also included in this study.
• Swertiamarin showed neuroprotective effect against rotenone-induced degeneration of dopaminergic neurons by ameliorating neuroinflammation and alpha-synuclein accumulation’ Under the guidance of Dr. Amit Khairnar. Animals handing, expertise stereotactic surgery (intrastriatal stereotactic rotenone injection in mice brain), performed various animals’ behavioral studies, after completion of study sacrifice and transcardially perfused the animals with 4%PFA and saline, isolation of different parts of brains, like striatum, cortex and whole brain. Performed western blotting of different protein according to our cell signaling cascade. Processed the brain tissue for cryo-sectioning, analyze alpha synuclein expression in Substantia Nigra (SN) through immunohistochemistry (IHC) staining and to check the degeneration of Tyrosine hydroxylase positive (TH+) neurons through IHC (DAB staining) in striatum and subtania nigra pars compacta (SNc) region of brain.
• Alpha mangostin confers neuroprotection against rotenone-induced Parkinson’s disease via modulating autophagy and AMPK signaling’ Under the guidance of Dr. Amit Khairnar. Assisting in animals handling and manuscript writing.

Total Webinar/Workshops/FDPs Attended: –

• Participated 5^th International FDP on Emerging trends in Neurodegerative disorder: Diagnostic and therapeutic, held on 5-9 May 2025, organized by the DYP DPU School of Pharmacy and Research, Pune with APTI central, APTI Women’s forum- Western zone and the AIMST University, Malyesia.
• Selected and Participated in the Handson workshop on Next Generation sequencing study, held on 5-16 August, 2024, organized by GBRC, Gandhinagar, Gujarat
• Participated workshop (KARYASHALA) on Light Based Tools For Chemistry and Biology organized by IIT Gandhinagar (Dept. of Chemistry) associated with DST-SERB, Gandhinagar, India in February-March 2023.
• Participated workshop on Certificate Course on Research Orientation organized by Centre for Research-on-Research Directorate of Research, MAHE, Manipal in December 2018.